Your browser doesn't support javascript.
loading
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Kim, Stefano; François, Eric; André, Thierry; Samalin, Emmanuelle; Jary, Marine; El Hajbi, Farid; Baba-Hamed, Nabil; Pernot, Simon; Kaminsky, Marie-Christine; Bouché, Olivier; Desrame, Jérôme; Zoubir, Mustapha; Ghiringhelli, François; Parzy, Aurélie; De La Fouchardiere, Christelle; Smith, Denis; Deberne, Mélanie; Spehner, Laurie; Badet, Nicolas; Adotevi, Olivier; Anota, Amélie; Meurisse, Aurélia; Vernerey, Dewi; Taieb, Julien; Vendrely, Véronique; Buecher, Bruno; Borg, Christophe.
  • Kim S; Department of Oncology, University Hospital of Besancon, Centre Hospitalier Universitaire de Besançon, Besançon, France; Department of Oncology and Radiotherapy, Hôpital Nord Franche Comté, Montbéliard, France; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, Fra
  • François E; Medical Oncology Department, Centre Antoine-Lacassagne, Nice, France.
  • André T; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR) Oncology Multidisciplinary Group, Paris, France; Department of Medical Oncology, Hôpital Saint Antoine, Assistance Publique Hôpitaux de Paris and Sorbonne Universités, Paris, France.
  • Samalin E; Department of Oncology, Institut du Cancer de Montpellier, Montpellier, France.
  • Jary M; Department of Oncology, University Hospital of Besancon, Centre Hospitalier Universitaire de Besançon, Besançon, France; Department of Oncology and Radiotherapy, Hôpital Nord Franche Comté, Montbéliard, France; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, Fra
  • El Hajbi F; Department of Oncology, Centre Oscar Lambret, Lille, France.
  • Baba-Hamed N; Department of Oncology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
  • Pernot S; Department of Oncology, Hôpital Européen Georges-Pompidou, Paris, France.
  • Kaminsky MC; Department of Oncology, Institut de Cancérologie de Lorraine, Nancy, France.
  • Bouché O; Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France; Department of Oncology, Centre Hospitalier Universitaire de Reims, Reims, France.
  • Desrame J; Department of Oncology, Hôpital Privé Jean Mermoz, Lyon, France.
  • Zoubir M; Department of Oncology, Hôpital Privé des Peupliers, Paris, France.
  • Ghiringhelli F; Department of Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Parzy A; Department of Oncology, Centre François Baclesse, Caen, France.
  • De La Fouchardiere C; Department of Oncology, Centre Léon Bérard, Lyon, France.
  • Smith D; Department of Oncology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Deberne M; Department of Oncology, Centre Hospitalier Lyon Sud, Lyon, France.
  • Spehner L; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France.
  • Badet N; Department of Oncology, Clinique Saint Vincent, Besançon, France.
  • Adotevi O; Department of Oncology, University Hospital of Besancon, Centre Hospitalier Universitaire de Besançon, Besançon, France; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France.
  • Anota A; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France; French National Platform Quality of Life and Cancer, Besançon, France.
  • Meurisse A; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.
  • Vernerey D; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR) Oncology Multidisciplinary Group, Paris, France.
  • Taieb J; Department of Oncology, Hôpital Européen Georges-Pompidou, Paris, France.
  • Vendrely V; Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France; Department of Oncology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Buecher B; Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France; Department of Oncology, Institut Curie, Paris, France.
  • Borg C; Department of Oncology, University Hospital of Besancon, Centre Hospitalier Universitaire de Besançon, Besançon, France; Department of Oncology and Radiotherapy, Hôpital Nord Franche Comté, Montbéliard, France; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, Fra
Lancet Oncol ; 19(8): 1094-1106, 2018 08.
Article en En | MEDLINE | ID: mdl-30042063
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Metástasis de la Neoplasia / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Metástasis de la Neoplasia / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article